Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cholangiocarcinoma Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03684811
What this trial is testing

FT-2102 in Patients With Advanced Solid Tumors and Gliomas With an IDH1 Mutation

Who this might be right for
Cohort 1a and 1b: Glioma (Advanced Gliomas and Glioblastoma Multiforme)Cohort 2a and 2b: Hepatobiliary Tumors (Hepatocellular Carcinoma, Bile Duct Carcinoma, Intrahepatic Cholangiocarcinoma, Other Hepatobiliary Carcinomas)Cohort 3a and 3b: Chondrosarcoma+2 more
Forma Therapeutics, Inc. 93
Testing effectiveness (Phase 2)Looking for participantsNCT07169734
What this trial is testing

Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors

Who this might be right for
Cervical Squamous Cell CarcinomaSquamous Non-small-cell Lung CancerColorectal Cancer+2 more
Alentis Therapeutics AG 180
Not applicableActive Not RecruitingNCT07573514
What this trial is testing

Patients With Primary Biliary Cholangitis

Who this might be right for
Primary Biliary CholangitisIntrahepatic Bile Duct CancerCancer Liver
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 2,000
Early research (Phase 1)Ended earlyNCT05432193
What this trial is testing

FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER)

Who this might be right for
Pancreatic Ductal AdenocarcinomaColorectal CancerEsophageal Cancer+4 more
POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company 20
Early research (Phase 1)Active Not RecruitingNCT02379377
What this trial is testing

18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant

Who this might be right for
Adult Hepatocellular CarcinomaResectable Hepatocellular CarcinomaCholangiocarcinoma+2 more
M.D. Anderson Cancer Center 110
Not applicableStudy completedNCT06381648
What this trial is testing

Detecting Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma (LyMIC)

Who this might be right for
CholangiocarcinomaCholangiocarcinoma, IntrahepaticCholangiocarcinoma Resectable+1 more
City of Hope Medical Center 230
Not applicableLooking for participantsNCT07717437
What this trial is testing

DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.

Who this might be right for
Liver CancerLiver Metastases
Maastricht University Medical Center 350
Testing effectiveness (Phase 2)Study completedNCT03250273
What this trial is testing

A Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma

Who this might be right for
Metastatic CholangiocarcinomaCholangiocarcinomaPancreatic Cancer+3 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 44
Not applicableStudy completedNCT06570174
What this trial is testing

Oral Protein Supplements for Nutritional and Quality of Life Improvement After Pancreatic Resection in Elderly Patients

Who this might be right for
Pancreatic CancerCholangiocarcinomaIntraductal Papillary Mucinous Neoplasm+2 more
Yonsei University 60
Testing effectiveness (Phase 2)Looking for participantsNCT04299581
What this trial is testing

Cryoablation Combined with Anti-PD-1 Antibody in Patients with Advanced Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
Fudan University 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT06717464
What this trial is testing

Toripalimab Combined With Capecitabine as Postoperative Adjuvant Therapy for Patients With Resectable Advanced Extrahepatic Biliary Tract Cancer

Who this might be right for
Gallbladder CancerHilar CholangiocarcinomaDistal Cholangiocarcinoma
Tianjin Medical University Cancer Institute and Hospital 110
Not applicableUnknownNCT05721963
What this trial is testing

Study on the Accuracy of Proteomics in Evaluating Lymph Node Metastasis Status in Cholangiocarcinoma Patients

Who this might be right for
Cholangiocarcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 30
Not applicableNot Yet RecruitingNCT07311798
What this trial is testing

Impact of Vascular Resection on Survival and Postoperative Outcomes in Patients With Hilar Cholangiocarcinoma: A Retrospective Study

Who this might be right for
Cholangiocarcinoma, Hilar
Yongjun Chen 300
Early research (Phase 1)Study completedNCT01643499
What this trial is testing

Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasAdenocarcinoma of the GallbladderAdenocarcinoma of Unknown Primary+37 more
University of Chicago 79
Very early researchLooking for participantsNCT07595237
What this trial is testing

A IIT Study of 177Lu-DOTA-SNA040

Who this might be right for
Advanced Solid Tumors (Such as Gastric Cancer)Advanced Solid Tumors (Such as Adenocarcinoma at the Gastroesophageal Junction)Advanced Solid Tumors (Such as Pancreatic Cancer)+1 more
SmartNuclide Biopharma 12
Large-scale testing (Phase 3)WithdrawnNCT00253617
What this trial is testing

Stent Placement With or Without Photodynamic Therapy Using Porfimer Sodium as Palliative Treatment in Treating Patients With Stage III or Stage IV Cholangiocarcinoma That Cannot Be Removed By Surgery

Who this might be right for
Cholangiocarcinoma of the Extrahepatic Bile DuctCholangiocarcinoma of the GallbladderUnresectable Extrahepatic Bile Duct Cancer+3 more
Jonsson Comprehensive Cancer Center
Not applicableAvailableNCT06370013
What this trial is testing

Rollover Study to Provide Continued Access to TT-00420 (Tinengotinib) for Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsCholangiocarcinoma
TransThera Sciences (Nanjing), Inc.
Testing effectiveness (Phase 2)Active Not RecruitingNCT05211323
What this trial is testing

Determine Whether Chemotherapy and Atezolizumab is Better Than Chemotherapy, Bevacizumab and Atezolizumab in Patients With Advanced Liver Cancer

Who this might be right for
Combined Hepatocellular Carcinoma and CholangiocarcinomaStage III Liver CancerStage IV Liver Cancer
National Cancer Institute (NCI) 4
Testing effectiveness (Phase 2)Study completedNCT02699606
What this trial is testing

Evaluate the Clinical Efficacy of JNJ-42756493 (Erdafitinib), A Pan-Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinase Inhibitor, In Asian Participants With Advanced Non-Small-Cell Lung Cancer, Urothelial Cancer, Esophageal Cancer Or Cholangiocarcinoma

Who this might be right for
Neoplasm
Janssen Research & Development, LLC 35
Not applicableWithdrawnNCT03563352
What this trial is testing

Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer

Who this might be right for
Breast CarcinomaCholangiocarcinomaColorectal Carcinoma+4 more
University of Southern California
Next Page